Clinical research company Medpace Holdings (NASDAQ:MEDP) in Q4 CY2024, with sales up 7.7% year on year to $536.6 million. On ...
Madison Investments, an investment advisor, released its “Madison Small Cap Fund” fourth-quarter 2024 investor letter. A copy ...
Q4 2024 Earnings Call Transcript February 11, 2025 Operator: And good day, ladies and gentlemen, and welcome to the Medpace ...
Clinical research company Medpace Holdings (NASDAQ:MEDP) will be announcing earnings results tomorrow after market hours.
LOS ANGELES, CA / ACCESS Newswire / February 18, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is ...
Rhumbline Advisers lifted its position in Medpace Holdings, Inc. (NASDAQ:MEDP – Free Report) by 0.8% in the 4th quarter, according to its most recent 13F filing with the SEC. The institutional ...
What Happened? Shares of clinical research company Medpace Holdings (NASDAQ:MEDP) fell 8.7% in the pre-market session after ...
Earnings Call Insights: Medpace Holdings, Inc. (NASDAQ:MEDP) Q4 2024 CEO August Troendle noted that backlog cancellations in Q4 were within the normal range, with a book-to-bill ratio of 0.99 due to ...
Equities research analysts at William Blair decreased their Q3 2025 earnings estimates for Medpace in a research report ...